Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical
and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis,
prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to
lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and
antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration
of various approaches.
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright
policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.
Please see our Guide
for Authors for information on article submission. If you require any further information or help, please visit our support
pages: click here
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and handheld, we are able to supply the information you need in the most convenient format.